Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2014 May 1;32(21):2457-62. doi: 10.1016/j.vaccine.2014.02.090. Epub 2014 Mar 12.

Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A.

Author information

  • 1Vaccine Development Section, International Vaccine Institute, SNU Research Park, San 4-8, Nakseongdae-dong, Gwanak-gu, 151-919 Seoul, Republic of Korea; School of Chemical Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
  • 2Vaccine Development Section, International Vaccine Institute, SNU Research Park, San 4-8, Nakseongdae-dong, Gwanak-gu, 151-919 Seoul, Republic of Korea.
  • 3National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar EN6 3QG, Hertfordshire, UK.
  • 4School of Chemical Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
  • 5Vaccine Development Section, International Vaccine Institute, SNU Research Park, San 4-8, Nakseongdae-dong, Gwanak-gu, 151-919 Seoul, Republic of Korea. Electronic address: rcarbis@ivi.int.

Abstract

The O specific polysaccharide (OSP) of the lipopolysaccharide (LPS) of Salmonella enterica serovar Paratyphi A is a protective antigen and the target for vaccine development. LPS is the major constituent of the outer membrane of S. Paratyphi A with the OSP exposed on the surface, in addition to the cell associated LPS a large amount of free LPS was present in the fermentation broth. A purification method was developed to take advantage of both sources of LPS and to maximize recovery of OSP. After fermentation the bacterial cells were concentrated and washed, the permeate containing the free LPS was processed separately from the cells. The free LPS was concentrated and washed on a 100kD ultrafiltration membrane to remove low molecular weight impurities. The LPS was then detoxified by separation of the lipid A from the OSP using acid hydrolysis at 100°C, the precipitated lipid A was removed by 0.2μm membrane filtration. Contaminants were then removed by acid precipitation in the presence of sodium deoxycholate. The OSP was concentrated and washed with 1M NaCl then water using a 10kD ultrafiltration membrane then sterile filtered through a 0.2μm membrane filter. The cells were treated by acid hydrolysis at 100°C, the remaining cells, cell debris and precipitate was removed by centrifugation. The filtrate was then treated in the same way as described above for the free LPS. The combined yield of purified OSP from free LPS plus the cells was greater than 880mg/L of culture broth. The method developed yields large amounts of OSP, is scalable and compatible with cGMP so would be readily transferrable to developing country vaccine manufacturers for low cost production of vaccine against S. Paratyphi A.

Copyright © 2014 Elsevier Ltd. All rights reserved.

KEYWORDS:

Enteric fever vaccine; O-specific polysaccharide; Polysaccharide purification; Salmonella Paratyphi; Vaccine production

PMID:
24631090
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk